EWTX

EDGEWISE THERAPEUTICS INC COM

EWTX·28036F105·US·Common Stock·Healthcare - Biotechnology-Activist

EWTX (EDGEWISE THERAPEUTICS INC COM) is held by 125 institutional investors as of Q2 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($341M), BlackRock, Inc. ($268.4M), FMR LLC ($223M). Net institutional sentiment: Mixed.

125
Holders
(11 Elite)
$2.4B
Total Value
63% (130)
Consensus
82 buying - 48 selling
13F: Insider & Congress: Updated regularly
EWTX

Smart Money Verdict

View all
Loading verdict
Held by 125 funds
11 elite

Who's Trading

Source dates: Price Oct 9, 2026 · Insiders Oct 2, 2026 · Activists Aug 14, 2026 · Congress none

InsiderFCFox Jonathan CVest 308 shOct 1, 2026
ActivistBaker Bros. Advisors LPBaker Bros. Advisors LP3.4%Aug 14, 2026
ActivistPBParadigm BioCapital Advisors LP9.5%Aug 14, 2026
Checking access…

Top Holders

Checking access…
Action
Decreased
8.4M(-19.5%)$341M3.0%+121.54%
0
Increased
6.6M(+2.1%)$268.4M0.0%+46.52%
31
Increased
5.5M(+439.7%)$223M0.0%+3.80%
49
Increased
4.7M(+5.6%)$192.1M1.1%+75.78%
51
Increased
3.9M(+1.9%)$156.9M0.0%+34.54%
31
Decreased
3.7M(-43.7%)$150.4M0.8%+148.65%
0
Increased
2.2M(+21.5%)$88.3M0.0%+94.63%
36
Decreased
1.9M(-13.2%)$79.2M0.0%+74.07%
0
Increased
1.8M(+6.5%)$74.3M0.0%+140.15%
32
Increased
2.1M(+23.0%)$66.7M0.0%+36.81%
36
Increased
1.6M(+17.4%)$63.3M0.0%+47.74%
34
Increased
1.3M(+51.6%)$50.9M0.0%+24.62%
41
Decreased
1.1M(-6.6%)$46.3M0.0%+143.05%
0
Decreased
1.1M(-1.8%)$45.8M0.0%+112.45%
0
Increased
902,870(+14.4%)$36.7M0.0%+89.16%
33
Increased
816,518(+1076.1%)$33.2M0.0%-0.32%
47
Increased
786,456(+41.1%)$32M0.0%+21.10%
38
Increased
671,270(+16.4%)$27.3M0.0%+88.96%
33
Decreased
647,926(-21.6%)$26.3M0.0%+85.86%
0
Increased
620,532(+4.1%)$25.2M0.0%+142.08%
30

Showing 1-20 of 134

1 / 7
EWTXEWTXEDGEWISE THERAPEUTICS INC COM

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used